BCAA metabolic reprogramming identifies BCKDK as a therapeutic target in cancer.

Expert opinion on therapeutic targets2026Li Z, Zhou Y, Zhang L, et al.

Study designReview

SubjectUnknown

Record checks

Study design: Review
Subject: Unknown
Publication year: 2026
Source: doi.org
Abstract display: Not reproduced here
Publication status: Active
Status checked: 17 Aug 2026
Collected: 3 Aug 2026
Freshness: Current
Review stage: Automated
Record status: Published

How to read this record →

Abstract

cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。

DOI 10.1080/14728222.2026.2709804

PMID 42496184

View source →